reference/6790993

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6790993

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1737
issn	1525-1438 1048-891X
issueIdentifier	11
pageRange	1733-1737
publicationName	International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
startingPage	1733
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ddd78906adb84409650f987d61a0fbb0
bibliographicCitation	Slomovitz BM, Chelariu-Raicu A, Schmeler KM, Lu KH, Gershenson DM, Wolf J, Coleman RL. Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer. Int J Gynecol Cancer. 2020 Nov;30(11):1733–7. doi: 10.1136/ijgc-2020-001859. PMID: 33020204.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca05aa13a425dd9de634c0035d7bcb55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af0b176bcadc063d620f634813d037eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2944-9488 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5985a09614205c7ff8620d6f27bc5e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aed711a962b47ca11571a4d859239f05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bdace4ec32b41d4f1fe2d7c15988c2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9670-4189
date	2020-10-05^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1136/ijgc-2020-001859 https://pubmed.ncbi.nlm.nih.gov/33020204
isPartOf	https://portal.issn.org/resource/ISSN/1525-1438 https://portal.issn.org/resource/ISSN/1048-891X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22047
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer
discusses	http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0422675 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M000626416
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016889Q000188 http://id.nlm.nih.gov/mesh/D000068818Q000008 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D000074322Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000068818Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000074322Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D066246
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9950 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6868 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Showing number of triples: 1 to 49 of 49.